Repository logo
 

Pulse Pressure Impairs Cognition via White Matter Disruption.

Accepted version
Peer-reviewed

Change log

Abstract

BACKGROUND: In older adults, elevated pulse pressure predicts cognitive decline, independent of overall blood pressure. It is proposed to compromise cerebrovascular integrity, potentially leading to brain damage, though the underlying mechanisms remain unclear. We hypothesized that pulse pressure affects cognition by disrupting white matter microstructure, and that it does so independently of other cardiovascular risk factors. METHODS: Latent indices of pulse pressure, overall blood pressure, and heart rate variability were estimated in a cross-sectional, population-based cohort (n=708, aged 18-88 years). An indicator of white matter microstructure was derived from diffusion-weighted imaging, termed the peak width of skeletonized mean diffusivity (PSMD). Cognitive function was assessed using measures of processing speed. RESULTS: In robust regression, pulse pressure was significantly associated with PSMD, with PSMD also being associated with processing speed. Thus, higher pulse pressure was associated with greater white matter disruption, which in turn was associated with slower processing. This motivated testing whether PSMD mediates the effects of pulse pressure on processing speed using structural equation models. PSMD mediated this effect, accounting for 72% of the effect after adjusting for age, and remained significant after adjusting for other cardiovascular factors. We then expanded the model to show that vascular-related changes in processing speed also drive changes in higher cognitive functions. CONCLUSIONS: High pulse pressure disrupts the microstructural integrity of white matter in the brain, leading to slower processing speed. We propose that better management of pulse pressure could help to preserve white matter integrity and reduce cognitive decline in later life.

Description

Journal Title

Hypertension

Conference Name

Journal ISSN

0194-911X
1524-4563

Volume Title

Publisher

Wolters Kluwer

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/M011194/1)
Biotechnology and Biological Sciences Research Council (2274385)
Alzheimer's Society (602)
Guarantors of Brain (Unknown)
Biotechnology and Biological Sciences Research Council (BB/H008217/1)
Cam-CAN was supported by the Biotechnology and Biological Sciences Research Council Grant BB/H008217/1. D.L.O.K. was supported by a Doctoral Training Programme studentship awarded by the Biotechnology and Biological Sciences Research Council (BBSRC BB/M011194/1) K.A.T. was supported by Fellowship awards from the Guarantors of Brain (G101149) and Alzheimer’s Society, UK (grant number 602). R.N.A.H. was supported by the UK Medical Research Council (SUAG/046 G101400) and the European Union’s Horizon 2020 research and innovation programme (‘LifeBrain’, Grant Agreement No. 732592). J.B.R. is funded by the Welcome Trust (220258), the Cambridge University Centre for Frontotemporal Dementia, the Medical Research Council (MC_UU_00030/14; MR/T033371/1 ); the National Institute for Health Research Cambridge Biomedical Research Centre (NIHR203312: BRC-1215-20014) and the Holt Fellowship. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. For the purpose of open access, the author has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.